Keep checking for updates and new content.

Newsletter April 2017

by jroth on April 10, 2017

Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter. In this Issue: Join us on Father’s day morning for our annual “Do it for dads” Walk Run! Jan. Awareness Night: Dr. Raj Satkunasivam: The future of PSA-based prostate cancer screening: screening smarter and individualized risk assessment We’d like to welcome a new […]

{ 0 comments }

How to cut YOUR chances of getting cancer

by Jim Barney on April 9, 2017

Medical journalist Anna Magee reveals the eight proven ways to lower your risk. Read the article here.

{ 0 comments }

Leading researchers recommend major change in prostate cancer treatment

April 9, 2017

Leading American and British cancer researchers are urging that all men with advanced prostate cancer strongly consider being tested for inherited gene mutations — both to help steer their treatment and to alert family members who themselves might be at increased risk for a range of cancers. Read the article here.

Read the article or watch the video →

Prostate Cancer Study Details Value of Treatments

April 9, 2017

A new study offers important information to men who are facing difficult decisions about how to treat prostate cancer in its early stages, or whether to treat it at all. Researchers followed patients for 10 years and found no difference in death rates between men who were picked at random to have surgery or radiation, […]

Read the article or watch the video →

New PET scan can detect prostate cancer earlier than MRIs and CT scans

April 9, 2017

Loyola Medicine is the first center in the Midwest to offer the first effective PET/CT scan for prostate cancer patients. The scan can detect the location and extent of cancer that has recurred after initial treatment and spread to other parts of the body. Prostate PET/CT scans can detect cancer earlier than either CT scans […]

Read the article or watch the video →

New way to identify patients at risk for aggressive prostate cancer

April 9, 2017

Scientists at Cedars-Sinai Medical Center have developed a new way to identify which prostate cancer patients are likely to develop aggressive types of the disease even if their tumors at first appear to be lower risk. Read the article here.

Read the article or watch the video →

Biolyse Pharma stymied in effort to make cheaper version of pricey prostate cancer drug

April 9, 2017

A small Canadian company has waded into a U.S. drug price controversy by offering to make an expensive prostate cancer drug for a fraction of the price. Right now Xtandi costs U.S. patients as much as $129,000 US a year, or about $90 per pill. St. Catharines, Ont.-based Biolyse Pharma says it can make the […]

Read the article or watch the video →

Prostate Cancer Treatment Breakthrough

April 9, 2017

Scientists with Deakin’s School of Medicine have found that, when coupled with the milk protein lactoferrin, the chemotherapy drug Doxorubicin (Dox) can be delivered directly into the nucleus of prostate cancer cells and will kill them cells as well as drug resistant cancer stem cells, without any side-effects. Read the article here.

Read the article or watch the video →

What influences opting out of active surveillance?

April 9, 2017

A man’s race/ethnicity might influence decision-making regarding opting for active treatment as well as undergoing serial biopsies during active surveillance, according to a recent study. Read the article here.

Read the article or watch the video →

Elevated cholesterol, triglycerides increase prostate cancer recurrence risk

April 9, 2017

Elevated cholesterol and triglycerides increase prostate cancer recurrence risk, according to research. Read the article here.

Read the article or watch the video →